IDH2 and glioblastoma: In another large series of glioblastoma patients without IDH mutations, a ≥90% extent of resection was achieved in 87.5% of cases operated with 5-ALA, 77.3% with fluorescein sodium, and 80% with the combined use of both fluorophores, with no significant differences between groups (p = 0.783) [20].